Bredt David's Form 4 filing
Rapport Therapeutics, Inc. (RAPP) · filed Feb 19, 2026
- Accession no.
- 0001193125-26-059883
- Filed
- Feb 19, 2026
- Trade date
- Feb 17-19, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $246.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bredt DavidCIK 0002022087 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Common Stock | SSaleDisposed | −900 | $28.02 | −$25,218 | 394,675 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −5,400 | $28.95 | −$156,330 | 389,275 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −2,200 | $29.59 | −$65,098 | 387,075 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseAcquired | +6,000 | $1.80 | +$10,800 | 393,075 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | Common Stock | MOption exerciseDisposed | −6,000 | $0.00 | $0 | 88,080 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.